Suicide, and Other Treatment (DrugWonks.com)
The risk of suicide related to selective serotonin reuptake inhibitors (SSRIs) has recently developed into a heated and emotion-fraught issue. In his entry, blogger Peter Pitts discusses SSRIs studies, suicide rates, and the various treatments available to people with clinical depression.
Ketek Crisis Continues (Eye On FDA)
Citing a recent ABC News report about sanofi-aventis' embattled antibiotic Ketek, blogger Mark Senak discusses Sen. Chuck Grassley's criticism of the FDA about the issue, and lambastes the agency's "continued inability to respond with a communications strategy in the face of a crisis and the intrinsic link between the image of the agency and the image of the pharmaceutical industry itself."